CW, C., A, O., CS, E., H, G., WG, L., SM, B., & DF, H. (2022). Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease. Frontiers in microbiology, 13, 1059115. https://doi.org/10.3389/fmicb.2022.1059115
Chicago Style (17th ed.) CitationCW, Cai, O'Shea A, Eickhoff CS, Guo H, Lewis WG, Beverley SM, and Hoft DF. "Use of Leishmania Major Parasites Expressing a Recombinant Trypanosoma Cruzi Antigen as Live Vaccines Against Chagas Disease." Frontiers in Microbiology 13 (2022): 1059115. https://doi.org/10.3389/fmicb.2022.1059115.
MLA (9th ed.) CitationCW, Cai, et al. "Use of Leishmania Major Parasites Expressing a Recombinant Trypanosoma Cruzi Antigen as Live Vaccines Against Chagas Disease." Frontiers in Microbiology, vol. 13, 2022, p. 1059115, https://doi.org/10.3389/fmicb.2022.1059115.